The present invention relates to a process for the preparation of biologically active, dimeric, TGF-.beta. (Transforming Growth Factor type .beta.), to novel TGF-.beta.s, and pharmaceutical compositions comprising it. TGF-.beta. produced according to the invention can be used for the promotion and